• Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
Monday, February 6, 2023
Massachusetts Digital News
  • Home
  • US
  • Business
  • World
  • Boston
  • Worcester
  • Springfield
  • Cambridge
  • Lowell
  • Brockton
  • Press Releases
  • Videos
No Result
View All Result
  • Home
  • US
  • Business
  • World
  • Boston
  • Worcester
  • Springfield
  • Cambridge
  • Lowell
  • Brockton
  • Press Releases
  • Videos
No Result
View All Result
No Result
View All Result
Home Cambridge

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Expected To Announce Earnings Of -$0.14 Per Share

by NewsReporter
January 16, 2022
in Cambridge
infinity-pharmaceuticals,-inc-(nasdaq:infi)-expected-to-announce-earnings-of-$0.14-per-share
Share on FacebookShare on Twitter

Infinity Pharmaceuticals logoWall Street analysts forecast that Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) will report earnings per share of ($0.14) for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Infinity Pharmaceuticals’ earnings, with the highest EPS estimate coming in at ($0.13) and the lowest estimate coming in at ($0.15). Infinity Pharmaceuticals posted earnings per share of ($0.17) in the same quarter last year, which would indicate a positive year over year growth rate of 17.6%. The firm is expected to report its next earnings results on Tuesday, March 15th.

On average, analysts expect that Infinity Pharmaceuticals will report full year earnings of ($0.53) per share for the current fiscal year, with EPS estimates ranging from ($0.55) to ($0.52). For the next fiscal year, analysts anticipate that the company will post earnings of ($0.64) per share, with EPS estimates ranging from ($0.76) to ($0.47). Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Infinity Pharmaceuticals.

Infinity Pharmaceuticals (NASDAQ:INFI) last issued its earnings results on Tuesday, November 2nd. The biotechnology company reported ($0.12) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.02. The firm had revenue of $0.43 million for the quarter, compared to analyst estimates of $0.45 million. Infinity Pharmaceuticals had a negative net margin of 2,398.81% and a negative return on equity of 172.12%. During the same quarter last year, the business posted ($0.16) earnings per share.

Several equities analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Infinity Pharmaceuticals from a “buy” rating to a “sell” rating in a research note on Tuesday, January 11th. HC Wainwright reaffirmed a “buy” rating and set a $9.00 price target on shares of Infinity Pharmaceuticals in a research note on Monday, December 13th. One research analyst has rated the stock with a sell rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Infinity Pharmaceuticals has an average rating of “Buy” and a consensus price target of $8.88.

(Ad)

There aren’t many days left on the calendar… and yet the global semiconductor market grew to $466.2 billion – in spite of the pandemic.

Better still, the chip shortage has created huge opportunities for recurring success.

These four tech companies are well-positioned to take advantage of this rapidly growing demand.

Shares of INFI stock traded up $0.02 during trading hours on Friday, hitting $1.43. 904,511 shares of the company’s stock traded hands, compared to its average volume of 1,723,982. The stock’s 50 day simple moving average is $2.23 and its 200 day simple moving average is $2.72. The stock has a market cap of $127.28 million, a PE ratio of -2.51 and a beta of 1.93. Infinity Pharmaceuticals has a 12 month low of $1.37 and a 12 month high of $5.98.

A number of large investors have recently bought and sold shares of INFI. BlackRock Inc. grew its holdings in shares of Infinity Pharmaceuticals by 201.2% during the second quarter. BlackRock Inc. now owns 6,041,344 shares of the biotechnology company’s stock valued at $18,065,000 after buying an additional 4,035,328 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Infinity Pharmaceuticals by 23.7% during the second quarter. Vanguard Group Inc. now owns 4,382,805 shares of the biotechnology company’s stock valued at $13,105,000 after buying an additional 838,751 shares during the last quarter. Polar Capital Holdings Plc acquired a new position in shares of Infinity Pharmaceuticals during the third quarter valued at about $8,550,000. Geode Capital Management LLC grew its holdings in shares of Infinity Pharmaceuticals by 22.6% during the third quarter. Geode Capital Management LLC now owns 1,734,032 shares of the biotechnology company’s stock valued at $5,930,000 after buying an additional 319,114 shares during the last quarter. Finally, Two Sigma Advisers LP grew its holdings in shares of Infinity Pharmaceuticals by 45.3% during the third quarter. Two Sigma Advisers LP now owns 1,693,200 shares of the biotechnology company’s stock valued at $5,791,000 after buying an additional 527,800 shares during the last quarter. Institutional investors and hedge funds own 52.10% of the company’s stock.

Infinity Pharmaceuticals Company Profile

Infinity Pharmaceuticals, Inc operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.

Further Reading: What is a front-end load?

Get a free copy of the Zacks research report on Infinity Pharmaceuticals (INFI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Infinity Pharmaceuticals (NASDAQ:INFI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Infinity Pharmaceuticals right now?

Before you consider Infinity Pharmaceuticals, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Infinity Pharmaceuticals wasn’t on the list.

While Infinity Pharmaceuticals currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here


Read More Here

Related Posts

head-to-head-survey:-voyager-therapeutics-(nasdaq:vygr)-&-surface-oncology-(nasdaq:surf)

Head-To-Head Survey: Voyager Therapeutics (NASDAQ:VYGR) & Surface Oncology (NASDAQ:SURF)

by Duong
April 14, 2022
0

Posted by admin on Apr 14th, 2022 Voyager Therapeutics (NASDAQ:VYGR – Get Rating) and Surface Oncology (NASDAQ:SURF – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, valuation, analyst recommendations, risk...

energy-workshop-–-announcements-–-e-flux

Energy Workshop – Announcements – E-Flux

by Duong
April 13, 2022
0

The first edition of the Norman Foster Foundation’s Energy Workshop will take place from April 25–29, 2022 with the support of GS Energy. “With energy, we stand on the shoulders of giants with our heads in the clouds,” states the workshop’s Mentor, Luke Olsen. As he puts it, “we need to...

men’s-and-women’s-tennis-complete-successful-weekend-with-wins-over-columbia,-cornell-|-sports-|-the-harvard-crimson

Men’s And Women’s Tennis Complete Successful Weekend With Wins Over Columbia, Cornell | Sports | The Harvard Crimson

by NewsReporter
April 12, 2022
0

“One thing that our team has really come a long way in this semester is with our confidence and belief in ourselves,” said first-year Holly Fischer. “So I think that even though we were down, everyone who was playing was fighting so hard and really leaving everything out on the...

artist-pritika-chowdhry’s-‘anti-memorials’-illustrate-what-is-excluded-from-collective-memories-of-partition

Artist Pritika Chowdhry’s ‘anti-Memorials’ Illustrate What Is Excluded From Collective Memories Of Partition

by Duong
April 11, 2022
0

The Jallianwala Bagh Massacre is one of the most significant events in the history of the sub-continent. Many people, including women and children, lost their lives on April 13, 1919, the day of Baisakhi when General Reginald Edward Dy ordered soldiers to open fire on the gathering — camping in...

Massachusetts Digital News

© 2021 Massachusetts Digital News

Navigate Site

  • Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer

Follow Us

No Result
View All Result
  • Home
  • DMCA Policy
  • Medical Disclaimer
  • Privacy Policy
  • Disclosure
  • CCPA
  • Terms of Use

© 2021 Massachusetts Digital News

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT